RACHEL GEORGE: Open Payments
NPI 1255942371 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,304 in 120 payments from 25 companies in 2025. Trend: 2023 $1,528 · 2024 $2,031 · 2025 $2,304
Food & beverage: $2,304
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $346 |
| GlaxoSmithKline, LLC. | 13 | $258 |
| Novo Nordisk Inc | 14 | $250 |
| PFIZER INC. | 12 | $211 |
| Lilly USA, LLC | 8 | $174 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $172 |
| AstraZeneca Pharmaceuticals LP | 8 | $144 |
| Antares Pharma, Inc. | 4 | $79 |
| Corcept Therapeutics | 3 | $73 |
| Amgen Inc. | 4 | $72 |
Products named: VRAYLAR, TRELEGY ELLIPTA, Kerendia, MOUNJARO, NURTEC ODT, Ozempic, REXULTI, XYOSTED.
Industry payments across AL — which companies pay providers there.
